Risk-Based Monitoring has always been in use -- the industry just hasn’t had the technology to implement it. Sites are accustomed to dealing with the unique nuances that individual protocols may present, however the recent innovations in EDC and virtual workspaces have allowed these issues to be addressed in real-time and perhaps even anticipated in advance. The question now remains: will remote monitoring create an additional and unnecessary burden of responsibility at the site level, or will it make for a more efficient and profitable workflow dynamic?
If the Reinventing Remote Monitoring: The Implications of Innovation is important to your business, act now and make the appropriate connections. See the contact information below.
|Conference/Event Dates:||05/26/2016 - 05/26/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Professional Healthcare|
|Audience:||Clinical Trials professionals, including:
Clinical Site Selection/Management Personnel
Clinical Site Coordinators (CRCs)
Clinical Research Associates/Monitors (CRAs)
Clinical Trial Managers (CTMs)
Clinical Operations & Project Management
Compliance & Regulatory Affairs
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.